SCHEMBL3564197

SCHEMBL3564197

COC(=O)c1ccc2c(C3CCCCC3)c(-c3ccccc3NC(=O)OC(C)(C)C)n(CCC(=O)O)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.37
MMP12 P39900 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2C19 P33261 3/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
FABP4 P15090 2/20 0.35
CNR2 P34972 3/20 0.35
SCN9A Q15858 2/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
CHRM3 P20309 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563946 0.94 PRKCA (0.35) PRKCAMMP12CYP3A4CYP2C19CYP2D6
SCHEMBL923678 0.89 PRKCA (0.36) PRKCAMMP12CYP3A4CYP2C19CYP2D6
SCHEMBL3571468 0.84 FABP4 (0.41) PRKCAMMP12USP2POLBCYP3A4
SCHEMBL772324 0.80 CNR2 (0.42) PRKCAMMP12CYP3A4CYP2C19CYP2D6
SCHEMBL772007 0.79 CNR2 (0.40) PRKCAMMP12CYP3A4CYP2C19CYP2D6
SCHEMBL3095978 0.77 PRKCA (0.44) PRKCAMMP12USP2POLBCYP3A4
SCHEMBL4825604 0.77 PRKCA (0.38) PRKCAMMP12CYP3A4CYP2C19CYP2D6
SCHEMBL771574 0.77 SCN9A (0.37) PRKCAMMP12USP2POLBCYP3A4
SCHEMBL3575525 0.77 PRKCA (0.37) PRKCAMMP12CNR2HDAC1HDAC8
SCHEMBL3575527 0.77 PRKCA (0.37) PRKCAMMP12CNR2HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662809-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-02-16 US disclosed
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US disclosed
EP-1807397-A2 TETRACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2007-07-18 EP disclosed
WO-2006046039-A2 TETRACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, HAVCR2 PRKCA 4232/4885MMP12 2495/4885USP2 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.